Thrivent Financial for Lutherans’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-281,256
Closed -$22.8M 2596
2021
Q4
$22.8M Sell
281,256
-6,103
-2% -$495K 0.04% 436
2021
Q3
$33.4M Buy
287,359
+18,304
+7% +$2.13M 0.07% 320
2021
Q2
$44.6M Buy
269,055
+11,199
+4% +$1.86M 0.09% 268
2021
Q1
$36M Buy
257,856
+28,935
+13% +$4.04M 0.08% 295
2020
Q4
$39.6M Sell
228,921
-24,802
-10% -$4.29M 0.09% 282
2020
Q3
$35.3M Sell
253,723
-6,838
-3% -$953K 0.09% 256
2020
Q2
$31.1M Buy
260,561
+176,111
+209% +$21M 0.09% 266
2020
Q1
$8.44M Buy
84,450
+32,635
+63% +$3.26M 0.03% 537
2019
Q4
$6.09M Buy
51,815
+5,470
+12% +$643K 0.02% 690
2019
Q3
$3.99M Buy
46,345
+1,346
+3% +$116K 0.01% 738
2019
Q2
$2.92M Buy
44,999
+569
+1% +$36.9K 0.01% 835
2019
Q1
$2.78M Sell
44,430
-39,676
-47% -$2.48M 0.01% 826
2018
Q4
$3.27M Sell
84,106
-78,218
-48% -$3.04M 0.01% 709
2018
Q3
$9.25M Sell
162,324
-19,541
-11% -$1.11M 0.03% 510
2018
Q2
$14.5M Sell
181,865
-30,265
-14% -$2.42M 0.05% 390
2018
Q1
$18.4M Buy
212,130
+1,870
+0.9% +$162K 0.06% 310
2017
Q4
$14.5M Hold
210,260
0.05% 361
2017
Q3
$19.1M Hold
210,260
0.07% 272
2017
Q2
$15.7M Buy
210,260
+10,030
+5% +$747K 0.07% 284
2017
Q1
$18.8M Buy
200,230
+7,960
+4% +$746K 0.08% 241
2016
Q4
$14M Buy
192,270
+45,820
+31% +$3.33M 0.06% 306
2016
Q3
$15.3M Buy
146,450
+17,050
+13% +$1.78M 0.07% 284
2016
Q2
$9.55M Buy
129,400
+21,600
+20% +$1.59M 0.05% 386
2016
Q1
$6.07M Buy
+107,800
New +$6.07M 0.03% 521